98 related articles for article (PubMed ID: 15102946)
1. Synergistic contributions of the functional groups of epinephrine to its affinity and efficacy at the beta2 adrenergic receptor.
Liapakis G; Chan WC; Papadokostaki M; Javitch JA
Mol Pharmacol; 2004 May; 65(5):1181-90. PubMed ID: 15102946
[TBL] [Abstract][Full Text] [Related]
2. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
[TBL] [Abstract][Full Text] [Related]
3. Mutagenesis within helix 6 of the human beta1-adrenergic receptor identifies Lysine324 as a residue involved in imparting the high-affinity binding state of agonists.
Zeitoun O; Santos NM; Gardner LA; White SW; Bahouth SW
Mol Pharmacol; 2006 Sep; 70(3):838-50. PubMed ID: 16760361
[TBL] [Abstract][Full Text] [Related]
4. Catechol-binding serines of beta(2)-adrenergic receptors control the equilibrium between active and inactive receptor states.
Ambrosio C; Molinari P; Cotecchia S; Costa T
Mol Pharmacol; 2000 Jan; 57(1):198-210. PubMed ID: 10617695
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of inverse agonists in cells overexpressing a constitutively active beta2-adrenoceptor and type II adenylyl cyclase.
Stevens PA; Milligan G
Br J Pharmacol; 1998 Jan; 123(2):335-43. PubMed ID: 9489623
[TBL] [Abstract][Full Text] [Related]
6. Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine.
Weitl N; Seifert R
J Pharmacol Exp Ther; 2008 Dec; 327(3):760-9. PubMed ID: 18772317
[TBL] [Abstract][Full Text] [Related]
7. Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses.
Baker JG; Hall IP; Hill SJ
Mol Pharmacol; 2003 Sep; 64(3):679-88. PubMed ID: 12920204
[TBL] [Abstract][Full Text] [Related]
8. Agonist binding and activation of the rat beta(1)-adrenergic receptor: role of Trp(134(3.28)), Ser(190(4.57)) and Tyr(356(7.43)).
Rezmann-Vitti LA; Louis SN; Nero TL; Jackman GP; Iakovidis D; Machida CA; Louis WJ
Biochem Pharmacol; 2004 Aug; 68(4):675-88. PubMed ID: 15276075
[TBL] [Abstract][Full Text] [Related]
9. Influence of a lysine 331 counterion on the pK(a) of aspartic acid 125: evidence for a salt-bridge interaction and role in alpha(1b)-adrenergic receptor activation.
Porter JE; Perez DM
J Pharmacol Exp Ther; 2000 Jan; 292(1):440-8. PubMed ID: 10604981
[TBL] [Abstract][Full Text] [Related]
10. Probing the salmeterol binding site on the beta 2-adrenergic receptor using a novel photoaffinity ligand, [(125)I]iodoazidosalmeterol.
Rong Y; Arbabian M; Thiriot DS; Seibold A; Clark RB; Ruoho AE
Biochemistry; 1999 Aug; 38(35):11278-86. PubMed ID: 10471277
[TBL] [Abstract][Full Text] [Related]
11. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
Bhattacharya S; Hall SE; Vaidehi N
J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis of important amino acid reveals unconventional homologous internalization of beta(1)-adrenergic receptor.
Hossain M; Rashid M; Bhuiyan MA; Nakamura T; Ozaki M; Nagatomo T
Life Sci; 2009 Aug; 85(7-8):339-44. PubMed ID: 19580817
[TBL] [Abstract][Full Text] [Related]
13. Mutation of Asn293 to Asp in transmembrane helix VI abolishes agonist-induced but not constitutive activity of the beta(2)-adrenergic receptor.
Hannawacker A; Krasel C; Lohse MJ
Mol Pharmacol; 2002 Dec; 62(6):1431-7. PubMed ID: 12435811
[TBL] [Abstract][Full Text] [Related]
14. Synergism of constitutive activity in alpha 1-adrenergic receptor activation.
Hwa J; Gaivin R; Porter JE; Perez DM
Biochemistry; 1997 Jan; 36(3):633-9. PubMed ID: 9012678
[TBL] [Abstract][Full Text] [Related]
15. Analysis of efficacy of chiral adrenergic agonists.
Patil PN; Li C; Kumari V; Hieble JP
Chirality; 2008 Mar; 20(3-4):529-43. PubMed ID: 18172836
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
17. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
[TBL] [Abstract][Full Text] [Related]
18. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis].
Shpakov AO; Derkach KV; Uspenskaia ZI; Shpakova EA; Kuznetsova LA; Plesneva SA; Pertseva MN
Tsitologiia; 2004; 46(4):317-25. PubMed ID: 15346790
[TBL] [Abstract][Full Text] [Related]
19. Effect of dithiothreitol on the beta-adrenergic receptor of S49 wild type and cyc- lymphoma cells: decreased affinity of the ligand-receptor interaction.
Clark RB; Green DA; Rashidbaigi A; Ruoho A
J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(3):203-20. PubMed ID: 6321573
[TBL] [Abstract][Full Text] [Related]
20. Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy.
Galandrin S; Bouvier M
Mol Pharmacol; 2006 Nov; 70(5):1575-84. PubMed ID: 16901982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
